(Q39020001)

8 September 2017

title

Purification of a modified form of bovine antithrombin III as an HIV-1 CD8+ T-cell antiviral factor (English)

1 reference

8 September 2017

3

Bruce D Walker

1 reference

8 September 2017

Ralf Geiben-Lynn

1

1 reference

8 September 2017

Nancy Brown

series ordinal

2

1 reference

8 September 2017

Andrew D Luster

series ordinal

4

1 reference

8 September 2017

language of work or name

English

0 references

publication date

20 August 2002

1 reference

Journal of Biological Chemistry

8 September 2017

published in

1 reference

8 September 2017

volume

277

1 reference

8 September 2017

issue

44

1 reference

8 September 2017

page(s)

42352-42357

1 reference

Spontaneous and antigen-induced production of HIV-inhibitory beta-chemokines are associated with AIDS-free status

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207079200

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207079200

Chemokines beyond inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207079200

Inhibition of HIV-1 infection by the beta-chemokine MDC

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207079200

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207079200

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207079200

In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207079200

CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207079200

CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207079200

CD8(+)-Cell antiviral factor activity is not restricted to human immunodeficiency virus (HIV)-specific T cells and can block HIV replication after initiation of reverse transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207079200

Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207079200

Noncytolytic inhibition of X4 virus by bulk CD8(+) cells from human immunodeficiency virus type 1 (HIV-1)-infected persons and HIV-1-specific cytotoxic T lymphocytes is not mediated by beta-chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207079200

Antiangiogenic activity of the cleaved conformation of the serpin antithrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207079200

A novel anti-angiogenic form of antithrombin with retained proteinase binding ability and heparin affinity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207079200

Preparative induction and characterization of L-antithrombin: a structural homologue of latent plasminogen activator inhibitor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207079200

Probing the heparin-binding domain of human antithrombin III with V8 protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207079200

The intact and cleaved human antithrombin III complex as a model for serpin-proteinase interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207079200

Heparin binding site, conformational change, and activation of antithrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207079200

Crystal structure of cleaved bovine antithrombin III at 3.2 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207079200

Truncation of macrophage-derived chemokine by CD26/ dipeptidyl-peptidase IV beyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207079200

Syndecan-4 as antithrombin receptor of human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207079200

Cell-surface heparan sulfate proteoglycan-mediated regulation of human neutrophil migration by the serpin antithrombin III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207079200

Optimal inhibition of X4 HIV isolates by the CXC chemokine stromal cell-derived factor 1 alpha requires interaction with cell surface heparan sulfate proteoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207079200

Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207079200

Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207079200

Secretory leukocyte protease inhibitor blocks infectivity of primary monocytes and mononuclear cells with both monocytotropic and lymphocytotropic strains of human immunodeficiency virus type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207079200

Secretory leukocyte protease inhibitor (SLPI): oxidation of SLPI does not explain its variable anti-HIV activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207079200

Secretory leukocyte protease inhibitor inhibits infection of monocytes and lymphocytes with human immunodeficiency virus type 1 but does not interfere with transcytosis of cell-associated virus across tight epithelial barriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207079200

Identification of a novel secretory leukocyte protease inhibitor-binding protein involved in membrane phospholipid movement

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207079200

Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207079200

HIV and thrombosis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207079200

CD8(+) cell noncytotoxic anti-human immunodeficiency virus response inhibits expression of viral RNA but not reverse transcription or provirus integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207079200

Mobile reactive centre of serpins and the control of thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207079200

CD8+ T lymphocyte-mediated inhibition of HIV-1 long terminal repeat transcription: a novel antiviral mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207079200

CD8+ T-cell-mediated suppression of HIV-1 long terminal repeat-driven gene expression is not modulated by the CC chemokines RANTES, macrophage inflammatory protein (MIP)-1 alpha and MIP-1 beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207079200

CD8+ T cell-mediated suppressive activity inhibits HIV-1 after virus entry with kinetics indicating effects on virus gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207079200

Oxidation of methionine residues in antithrombin. Effects on biological activity and heparin binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207079200

Characterization of a 90-100 kDa tumor-associated antigen in the sera of melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207079200

Antithrombin inhibits lipopolysaccharide-induced tissue factor and interleukin-6 production by mononuclear cells, human umbilical vein endothelial cells, and whole blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207079200

Antithrombin III inhibits nuclear factor kappaB activation in human monocytes and vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M207079200

21 January 2018

Identifiers

DOI

10.1074/JBC.M207079200

1 reference

8 September 2017

1 reference